JP2003212862A - Method for producing quinazolin-4-one derivative - Google Patents
Method for producing quinazolin-4-one derivativeInfo
- Publication number
- JP2003212862A JP2003212862A JP2002007014A JP2002007014A JP2003212862A JP 2003212862 A JP2003212862 A JP 2003212862A JP 2002007014 A JP2002007014 A JP 2002007014A JP 2002007014 A JP2002007014 A JP 2002007014A JP 2003212862 A JP2003212862 A JP 2003212862A
- Authority
- JP
- Japan
- Prior art keywords
- group
- derivative
- reaction
- acid derivative
- quinazolin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、アントラニル酸誘
導体からキナゾリン-4-オン誘導体を製造する方法に関
する。キナゾリン-4-オン誘導体は、医薬や農薬等の合
成中間体又は原料として有用な化合物である。TECHNICAL FIELD The present invention relates to a method for producing a quinazolin-4-one derivative from an anthranilic acid derivative. The quinazolin-4-one derivative is a compound useful as a synthetic intermediate or a raw material for medicines and agricultural chemicals.
【0002】[0002]
【従来の技術】従来、アントラニル酸誘導体からキナゾ
リン-4-オン誘導体を製造する方法としては、以下の方
法が知られている。EP 1029853には、5-ヨードアント
ラニル酸と酢酸ホルムアミジンとをエタノール中で20時
間反応させて、6-ヨードキナゾリン-4-オンを製造する
方法が開示されている。しかしながら、この方法では、
反応時間が長い上に、高価な酢酸ホルムアミジンを過剰
に使用しなければならないという問題があった。Che
m.Pharm.Bull.,46,1926(1998)には、アントラニル酸と
ホルムアミドとを反応させて、キナゾリン-4-オンを製
造する方法が開示されている。しかしながら、この方法
では、催奇性のあるホルムアミドを過剰に使用しなけれ
ばならないという問題があった。以上、いずれの方法も
種々の問題を含んでおり、キナゾリン-4-オン誘導体の
工業的製法としては有効ではなかった。2. Description of the Related Art Conventionally, the following methods have been known as a method for producing a quinazolin-4-one derivative from an anthranilic acid derivative. EP 1029853 discloses a method for producing 6-iodoquinazolin-4-one by reacting 5-iodoanthranilic acid and formamidine acetate in ethanol for 20 hours. However, with this method,
There is a problem that the reaction time is long and expensive formamidine acetate must be used in excess. Che
m.Pharm.Bull., 46 , 1926 (1998) discloses a method for producing quinazolin-4-one by reacting anthranilic acid with formamide. However, this method has a problem that teratogenic formamide must be used in excess. As described above, each of the methods has various problems and is not effective as an industrial method for producing a quinazolin-4-one derivative.
【0003】[0003]
【発明が解決しようとする課題】本発明の課題は、即
ち、上記問題点を解決し、温和な条件下、簡便な方法に
よって、アントラニル酸誘導体のアンモニウム塩からキ
ナゾリン-4-オン誘導体を高収率で製造出来る、工業的
に好適なキナゾリン-4-オン誘導体の製法を提供するも
のである。The object of the present invention is to solve the above-mentioned problems and to obtain a high yield of a quinazolin-4-one derivative from an ammonium salt of an anthranilic acid derivative by a simple method under mild conditions. The process for producing an industrially suitable quinazolin-4-one derivative that can be produced at a high rate is provided.
【0004】[0004]
【課題を解決するための手段】本発明の課題は、アンモ
ニアの存在下、一般式(1)The object of the present invention is to solve the problems of the general formula (1) in the presence of ammonia.
【0005】[0005]
【化4】 [Chemical 4]
【0006】(式中、R1、R2、R3及びR4は、同
一又は異なっていても良く、置換基を有していても良
い、反応に関与しない基を示す。なお、R1、R2、R
3及びR 4は、互いに結合して環を形成していても良
い。)で示されるアントラニル酸誘導体のアンモニウム
塩とギ酸誘導体とを反応させることを特徴とする、一般
式(2)(Where R is1, RTwo, RThreeAnd RFourIs the same
It may be one or different and may have a substituent.
Group which does not participate in the reaction. In addition, R1, RTwo, R
ThreeAnd R FourMay combine with each other to form a ring.
Yes. ) Ammonium of anthranilic acid derivative
General, characterized by reacting a salt with a formic acid derivative
Formula (2)
【0007】[0007]
【化5】 [Chemical 5]
【0008】(式中、R1、R2、R3及びR4は、前
記と同義である。)で示されるキナゾリン-4-オン誘導
体の製法によって解決される。This can be solved by a method for producing a quinazolin-4-one derivative represented by the formula (wherein R 1 , R 2 , R 3 and R 4 have the same meanings as described above).
【0009】[0009]
【発明の実施の形態】本発明において使用するアントラ
ニル酸誘導体のアンモニウム塩は、前記の一般式(1)
で示される。その一般式(1)において、R1、R2、
R3及びR4は、同一又は異なっていても良く、置換基
を有していても良い、反応に関与しない基であるが、具
体的には、例えば、水素原子、アルキル基、シクロアル
キル基、アラルキル基、アリール基、ハロゲン原子、ヒ
ドロキシル基、アルコキシル基、アルキルチオ基、ニト
ロ基、シアノ基、カルボニル基又はアミノ基(R1を除
く)を示す。なお、R1、R2、R3及びR4は、互い
に結合して環を形成していても良い。BEST MODE FOR CARRYING OUT THE INVENTION The ammonium salt of an anthranilic acid derivative used in the present invention has the above-mentioned general formula (1).
Indicated by. In the general formula (1), R 1 , R 2 ,
R 3 and R 4 may be the same or different and may have a substituent and are groups that do not participate in the reaction. Specifically, for example, a hydrogen atom, an alkyl group, a cycloalkyl group , An aralkyl group, an aryl group, a halogen atom, a hydroxyl group, an alkoxyl group, an alkylthio group, a nitro group, a cyano group, a carbonyl group or an amino group (excluding R 1 ). In addition, R 1 , R 2 , R 3 and R 4 may be bonded to each other to form a ring.
【0010】前記アルキル基としては、例えば、メチル
基、エチル基、プロピル基、ブチル基、ペンチル基、ヘ
キシル基、ヘプチル基、オクチル基、ノニル基、デシル
基等が挙げられる。なお、これらの基は、各種異性体を
含む。Examples of the alkyl group include methyl group, ethyl group, propyl group, butyl group, pentyl group, hexyl group, heptyl group, octyl group, nonyl group and decyl group. In addition, these groups include various isomers.
【0011】前記シクロアルキル基としては、例えば、
シクロプロピル基、シクロブチル基、シクロペンチル
基、シクロヘキシル基、シクロヘプチル基、シクロオク
チル基等が挙げられる。Examples of the cycloalkyl group include:
Examples thereof include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group and a cyclooctyl group.
【0012】前記アラルキル基としては、例えば、ベン
ジル基、フェネチル基、フェニルプロピル基等が挙げら
れる。なお、これらの基は、各種異性体を含む。Examples of the aralkyl group include a benzyl group, a phenethyl group and a phenylpropyl group. In addition, these groups include various isomers.
【0013】前記アリール基としては、例えば、フェニ
ル基、p-トリル基、ナフチル基、アントラニル基等が挙
げられる。なお、これらの基は、各種異性体を含む。Examples of the aryl group include a phenyl group, a p-tolyl group, a naphthyl group and an anthranyl group. In addition, these groups include various isomers.
【0014】前記ハロゲン原子としては、例えば、フッ
素原子、塩素原子、臭素原子、ヨウ素原子が挙げられ
る。Examples of the halogen atom include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
【0015】前記アルコキシル基としては、例えば、メ
トキシル基、エトキシル基、プロポキシル基等が挙げら
れる。なお、これらの基は、各種異性体を含む。Examples of the alkoxyl group include a methoxyl group, an ethoxyl group and a propoxyl group. In addition, these groups include various isomers.
【0016】前記アルキルチオ基としては、例えば、メ
チルチオ基、エチルチオ基、プロピルチオ基等が挙げら
れる。なお、これらの基は、各種異性体を含む。Examples of the alkylthio group include a methylthio group, an ethylthio group and a propylthio group. In addition, these groups include various isomers.
【0017】前記のアルキル基、シクロアルキル基、ア
ラルキル基、アリール基、アルコキシル基、アルキルチ
オ基又はアミノ基(R1を除く)は、置換基を有してい
ても良い。その置換基としては、炭素原子を介して出来
る置換基、酸素原子を介して出来る置換基、窒素原子を
介して出来る置換基、硫黄原子を介して出来る置換基、
ハロゲン原子等が挙げられる。The above alkyl group, cycloalkyl group, aralkyl group, aryl group, alkoxyl group, alkylthio group or amino group (excluding R 1 ) may have a substituent. As the substituent, a substituent formed via a carbon atom, a substituent formed via an oxygen atom, a substituent formed via a nitrogen atom, a substituent formed via a sulfur atom,
A halogen atom etc. are mentioned.
【0018】前記炭素原子を介して出来る置換基として
は、例えば、メチル基、エチル基、プロピル基、ブチル
基、ペンチル基、ヘキシル基等のアルキル基;シクロプ
ロピル基、シクロブチル基、シクロペンチル基、シクロ
ヘキシル基、シクロブチル基等のシクロアルキル基;ビ
ニル基、アリル基、プロペニル基、シクロプロペニル
基、シクロブテニル基、シクロペンテニル基等のアルケ
ニル基;ピロリジル基、ピロリル基、フリル基、チエニ
ル基等の複素環式アルケニル基;フェニル基、トリル
基、キシリル基、ビフェニル基、ナフチル基、アントリ
ル基、フェナントリル基等のアリール基;ホルミル基、
アセチル基、プロピオニル基、アクリロイル基、ピバロ
イル基、シクロヘキシルカルボニル基、ベンゾイル基、
ナフトイル基、トルオイル基等のアシル基(アセタール
化されていても良い);カルボキシル基;メトキシカル
ボニル基、エトキシカルボニル基等のアルコキシカルボ
ニル基;フェノキシカルボニル基等のアリールオキシカ
ルボニル基;トリフルオロメチル基等のハロゲン化アル
キル基;シアノ基が挙げられる。なお、これらの基は、
各種異性体を含む。Examples of the substituent formed via the carbon atom include alkyl groups such as methyl group, ethyl group, propyl group, butyl group, pentyl group and hexyl group; cyclopropyl group, cyclobutyl group, cyclopentyl group and cyclohexyl group. Group, cycloalkyl group such as cyclobutyl group; alkenyl group such as vinyl group, allyl group, propenyl group, cyclopropenyl group, cyclobutenyl group, cyclopentenyl group; heterocyclic group such as pyrrolidyl group, pyrrolyl group, furyl group and thienyl group Alkenyl group; phenyl group, tolyl group, xylyl group, biphenyl group, naphthyl group, anthryl group, aryl group such as phenanthryl group; formyl group,
Acetyl group, propionyl group, acryloyl group, pivaloyl group, cyclohexylcarbonyl group, benzoyl group,
Acyl group such as naphthoyl group and toluoyl group (may be acetalized); carboxyl group; alkoxycarbonyl group such as methoxycarbonyl group, ethoxycarbonyl group; aryloxycarbonyl group such as phenoxycarbonyl group; trifluoromethyl group etc. And a cyano group. In addition, these groups are
Including various isomers.
【0019】前記酸素原子を介して出来る置換基として
は、例えば、ヒドロキシル基;メトキシル基、エトキシ
ル基、プロポキシル基、ブトキシル基、ペンチルオキシ
ル基、ヘキシルオキシル基、ヘプチルオキシル基、ベン
ジルオキシル基等のアルコキシル基;フェノキシル基、
トルイルオキシル基、ナフチルオキシル基等のアリール
オキシル基が挙げられる。なお、これらの基は、各種異
性体を含む。Examples of the substituent formed via the oxygen atom include a hydroxyl group; a methoxyl group, an ethoxyl group, a propoxyl group, a butoxyl group, a pentyloxyl group, a hexyloxyl group, a heptyloxyl group and a benzyloxyl group. Alkoxyl group; phenoxyl group,
Examples thereof include aryloxyl groups such as a toluyloxyl group and a naphthyloxyl group. In addition, these groups include various isomers.
【0020】前記窒素原子を介して出来る置換基として
は、例えば、メチルアミノ基、エチルアミノ基、ブチル
アミノ基、シクロへキシルアミノ基、フェニルアミノ
基、ナフチルアミノ基等の第一アミノ基;ジメチルアミ
ノ基、ジエチルアミノ基、ジブチルアミノ基、メチルエ
チルアミノ基、メチルブチルアミノ基、ジフェニルアミ
ノ基等の第二アミノ基;モルホリノ基、ピペリジノ基、
ピペラジニル基、ピラゾリジニル基、ピロリジノ基、イ
ンドリル基等の複素環式アミノ基;イミノ基が挙げられ
る。なお、これらの基は、各種異性体を含む。Examples of the substituent formed through the nitrogen atom include primary amino groups such as methylamino group, ethylamino group, butylamino group, cyclohexylamino group, phenylamino group and naphthylamino group; dimethylamino. Groups, diethylamino groups, dibutylamino groups, methylethylamino groups, methylbutylamino groups, diphenylamino groups and other secondary amino groups; morpholino groups, piperidino groups,
Heterocyclic amino groups such as piperazinyl group, pyrazolidinyl group, pyrrolidino group and indolyl group; and imino groups. In addition, these groups include various isomers.
【0021】前記硫黄原子を介して出来る置換基として
は、例えば、メルカプト基;チオメトキシル基、チオエ
トキシル基、チオプロポキシル基等のチオアルコキシル
基;チオフェノキシル基、チオトルイルオキシル基、チ
オナフチルオキシル基等のチオアリールオキシル基等が
挙げられる。なお、これらの基は、各種異性体を含む。Examples of the substituent formed through the sulfur atom include a mercapto group; a thioalkoxyl group such as a thiomethoxyl group, a thioethoxyl group and a thiopropoxyl group; a thiophenoxyl group, a thiotoluyloxyl group, a thionaphthyl group. Examples thereof include thioaryloxyl groups such as oxyl groups. In addition, these groups include various isomers.
【0022】前記ハロゲン原子としては、フッ素原子、
塩素原子、臭素原子、ヨウ素原子が挙げられる。The halogen atom is a fluorine atom,
Examples thereof include chlorine atom, bromine atom and iodine atom.
【0023】なお、アントラニル酸誘導体のアンモニウ
ム塩は、例えば、アントラニル酸誘導体に、過剰量のア
ンモニアガス、液体アンモニア、アンモニア水又はアン
モニアの有機溶媒溶液(例えば、アンモニアメタノール
溶液、アンモニアジオキサン溶液等)を接触させること
によって容易に得ることが出来る化合物である(後の参
考例1〜4に記載)。The ammonium salt of the anthranilic acid derivative is obtained by adding an excess amount of ammonia gas, liquid ammonia, aqueous ammonia or an organic solvent solution of ammonia (for example, ammonia methanol solution, ammonia dioxane solution, etc.) to the anthranilic acid derivative. It is a compound that can be easily obtained by contact (described in Reference Examples 1 to 4 below).
【0024】本発明の反応において使用するギ酸誘導体
としては、例えば、ギ酸;ギ酸メチル、ギ酸エチル等の
ギ酸エステル類;オルトギ酸メチル、オルトギ酸エチル
等のオルトギ酸エステル類等が挙げられるが、好ましく
はギ酸エステル、オルトギ酸エステル、更に好ましくは
オルトギ酸エステル、特に好ましくはオルトギ酸メチ
ル、オルトギ酸エチルが使用される。Examples of the formic acid derivative used in the reaction of the present invention include formic acid; formic acid esters such as methyl formate and ethyl formate; orthoformate esters such as methyl orthoformate and ethyl orthoformate, and the like. Formic acid ester and orthoformate ester are used, more preferably orthoformate ester, particularly preferably methyl orthoformate and ethyl orthoformate are used.
【0025】前記ギ酸誘導体の使用量は、アントラニル
酸誘導体のアンモニウム塩1molに対して、好ましくは1.
0〜10mol、更に好ましくは1.1〜3.0molである。The amount of the formic acid derivative used is preferably 1. mol per 1 mol of the ammonium salt of the anthranilic acid derivative.
The amount is 0 to 10 mol, more preferably 1.1 to 3.0 mol.
【0026】本発明の反応は溶媒の存在下又は非存在下
において行われる。使用する溶媒としては、反応を阻害
するものでなければ特に限定されず、例えば、メタノー
ル、エタノール、イソプロピルアルコール、n-ブチルア
ルコール、t-ブチルアルコール等のアルコール類;N,N-
ジメチルホルムアミド、N-メチルピロリドン等のアミド
類;N,N'-ジメチルイミダゾリジノン等の尿素類;ジメ
チルスルホキシド等のスルホキシド類;ベンゼン、トル
エン、キシレン、メシチレン等の芳香族炭化水素類;塩
化メチレン、クロロホルム、ジクロロエタン等のハロゲ
ン化脂肪族炭化水素類等;アセトニトリル、プロピオニ
トリル等のニトリル類;ジエチルエーテル、テトラヒド
ロフラン、ジオキサン等のエーテル類が挙げられるが、
好ましくはアルコール類、ニトリル類、更に好ましくは
メタノール、エタノール、アセトニトリルが使用され
る。これらの溶媒は、単独又は二種以上を混合して使用
しても良い。The reaction of the present invention is carried out in the presence or absence of a solvent. The solvent used is not particularly limited as long as it does not inhibit the reaction, and examples thereof include alcohols such as methanol, ethanol, isopropyl alcohol, n-butyl alcohol and t-butyl alcohol; N, N-
Amides such as dimethylformamide and N-methylpyrrolidone; ureas such as N, N'-dimethylimidazolidinone; sulfoxides such as dimethylsulfoxide; aromatic hydrocarbons such as benzene, toluene, xylene, mesitylene; methylene chloride , Halogenated aliphatic hydrocarbons such as chloroform and dichloroethane; nitriles such as acetonitrile and propionitrile; ethers such as diethyl ether, tetrahydrofuran and dioxane.
Alcohols and nitriles are preferably used, and more preferably methanol, ethanol and acetonitrile are used. You may use these solvent individually or in mixture of 2 or more types.
【0027】前記溶媒の使用量は、反応液の均一性や攪
拌性等によって適宜調節するが、アントラニル酸誘導体
のアンモニウム塩1gに対して、好ましくは0〜50g、更に
好ましくは0〜20g、特に好ましくは0〜5gである。The amount of the solvent used is appropriately adjusted depending on the homogeneity and agitation property of the reaction solution, but is preferably 0 to 50 g, more preferably 0 to 20 g, particularly preferably 0 to 20 g, per 1 g of the ammonium salt of the anthranilic acid derivative. It is preferably 0 to 5 g.
【0028】本発明の反応は、例えば、アントラニル酸
誘導体のアンモニウム塩、ギ酸誘導体及び溶媒を混合し
て攪拌させる等の方法によって行われる。その際の反応
温度は、好ましくは40〜200℃、更に好ましくは50〜150
℃であり、反応圧力は特に制限されない。The reaction of the present invention is carried out by, for example, a method of mixing an ammonium salt of an anthranilic acid derivative, a formic acid derivative and a solvent and stirring the mixture. The reaction temperature in that case is preferably 40 to 200 ° C, more preferably 50 to 150.
The reaction pressure is not particularly limited.
【0029】なお、最終生成物であるキナゾリン-4-オ
ン誘導体は、反応終了後、例えば、濃縮、蒸留、再結
晶、カラムクロマトグラフィー等による一般的な方法に
よって単離・精製される。The final product, the quinazolin-4-one derivative, is isolated and purified after the reaction by a general method such as concentration, distillation, recrystallization, column chromatography and the like.
【0030】[0030]
【実施例】次に、実施例を挙げて本発明を具体的に説明
するが、本発明の範囲はこれらに限定されるものではな
い。EXAMPLES Next, the present invention will be specifically described with reference to examples, but the scope of the present invention is not limited to these.
【0031】参考例1(アントラニル酸アンモニウムの
合成)
攪拌装置及び温度計を備えた内容積50mlのガラス製容器
に、アントラニル酸5.0g(36.5mmol)及び15質量%アンモ
ニアメタノール溶液20ml(156mmol)を加え、室温で2時間
反応させた。反応終了後、反応液を減圧下で濃縮し、白
色固体として、アントラニル酸アンモニウム5.0gを得た
(単離収率:94%)。なお、アントラニル酸アンモニウム
の物性値は以下の通りであった。Reference Example 1 (Synthesis of ammonium anthranilate) 5.0 g (36.5 mmol) of anthranilic acid and 20 ml (156 mmol) of a 15% by mass ammonia methanol solution were placed in a glass container having an inner volume of 50 ml equipped with a stirrer and a thermometer. In addition, the mixture was reacted at room temperature for 2 hours. After the reaction was completed, the reaction solution was concentrated under reduced pressure to obtain 5.0 g of ammonium anthranilate as a white solid.
(Isolated yield: 94%). The physical properties of ammonium anthranilate are as follows.
【0032】融点(昇華);145〜146℃1
H-NMR(DMSO-d6,δ(ppm));6.37〜6.43(1H,m)、6.56(1
H,dd,J=1.2,8.1Hz)、6.95(6H,brs)、6.98〜7.04(1H,
m)、7.69〜7.72(1H,dd,J=1.8,7.8Hz)Melting point (sublimation): 145 to 146 ° C. 1 H-NMR (DMSO-d 6 , δ (ppm)); 6.37 to 6.43 (1 H, m), 6.56 (1
H, dd, J = 1.2,8.1Hz), 6.95 (6H, brs), 6.98 ~ 7.04 (1H,
m), 7.69 to 7.72 (1H, dd, J = 1.8,7.8Hz)
【0033】実施例1(キナゾリン-4-オンの合成)
内容積2mlのステンレス製耐圧容器に、参考例1と同様
な方法で合成したアントラニル酸アンモニウム280mg(1.
8mmol)、オルトギ酸メチル400mg(3.6mmol)及びメタノー
ル1.5mlを加え、120℃で2時間反応させた。反応終了
後、室温まで冷却し、反応液を高速液体クロマトグラフ
ィーにより分析(絶対定量法)したところ、キナゾリン
-4-オンが214mg生成していた(反応収率:81%)。Example 1 (Synthesis of quinazolin-4-one) 280 mg of ammonium anthranilate synthesized in the same manner as in Reference Example 1 (1.
8 mmol), methyl orthoformate 400 mg (3.6 mmol) and methanol 1.5 ml were added, and the mixture was reacted at 120 ° C. for 2 hours. After the reaction was completed, the reaction solution was cooled to room temperature and analyzed by high performance liquid chromatography (absolute quantitative method).
214 mg of 4-one was produced (reaction yield: 81%).
【0034】参考例2(4-クロロアントラニル酸アンモ
ニウムの合成)
攪拌装置及び温度計を備えた内容積50mlのガラス製容器
に、4-クロロアントラニル酸5.0g(29.1mmol)及び15質量
%アンモニアメタノール溶液20ml(156mmol)を加え、室
温で2時間反応させた。反応終了後、反応液を減圧下で
濃縮し、白色固体として、4-クロロアントラニル酸アン
モニウム5.0gを得た(単離収率:95%)。なお、4-クロロ
アントラニル酸アンモニウムは以下の物性値で示される
新規な化合物である。Reference Example 2 (Synthesis of ammonium 4-chloroanthranilate) In a glass container having an inner volume of 50 ml equipped with a stirrer and a thermometer, 5.0 g (29.1 mmol) of 4-chloroanthranilic acid and 15 mass% ammonia methanol A solution (20 ml, 156 mmol) was added, and the mixture was reacted at room temperature for 2 hours. After completion of the reaction, the reaction solution was concentrated under reduced pressure to obtain 5.0 g of ammonium 4-chloroanthranilate as a white solid (isolated yield: 95%). Ammonium 4-chloroanthranilate is a novel compound having the following physical properties.
【0035】融点(昇華);232〜233℃1
H-NMR(DMSO-d6,δ(ppm));6.43(1H,dd,J=2.4,8.4H
z)、6.69(1H,d,J=2.4Hz)、7.0(3H,brs)、7.69(1H,d,J=
8.4Hz)、11.0(3H,brs)Melting point (sublimation); 232 to 233 ° C. 1 H-NMR (DMSO-d 6 , δ (ppm)); 6.43 (1H, dd, J = 2.4,8.4H)
z), 6.69 (1H, d, J = 2.4Hz), 7.0 (3H, brs), 7.69 (1H, d, J =
8.4Hz), 11.0 (3H, brs)
【0036】実施例2(7-クロロキナゾリン-4-オンの
合成)
内容積2mlのステンレス製耐圧容器に、参考例2と同様
な方法で合成した4-クロロアントラニル酸アンモニウム
340mg(1.8mmol)、オルトギ酸メチル400mg(3.6mmol)及び
メタノール1.5mlを加え、120℃で2時間反応させた。反
応終了後、室温まで冷却し、反応液を高速液体クロマト
グラフィーにより分析(絶対定量法)したところ、7-ク
ロロキナゾリン-4-オンが176mg生成していた(反応収
率:54%)。Example 2 (Synthesis of 7-chloroquinazolin-4-one) Ammonium 4-chloroanthranilate synthesized in the same manner as in Reference Example 2 in a stainless steel pressure vessel having an internal volume of 2 ml.
340 mg (1.8 mmol), methyl orthoformate 400 mg (3.6 mmol) and methanol 1.5 ml were added and reacted at 120 ° C. for 2 hours. After completion of the reaction, the mixture was cooled to room temperature and analyzed by high performance liquid chromatography (absolute quantification method) to find that 176 mg of 7-chloroquinazolin-4-one was produced (reaction yield: 54%).
【0037】参考例3(5-クロロアントラニル酸アンモ
ニウムの合成)
攪拌装置及び温度計を備えた内容積50mlのガラス製容器
に、5-クロロアントラニル酸5.0g(29.1mmol)及び15質量
%アンモニアメタノール溶液20ml(156mmol)を加え、室
温で2時間反応させた。反応終了後、反応液を減圧下で
濃縮し、淡黄色固体として、5-クロロアントラニル酸ア
ンモニウム5.0gを得た(単離収率:95%)。なお、5-クロ
ロアントラニル酸アンモニウムは以下の物性値で示され
る新規な化合物である。Reference Example 3 (Synthesis of ammonium 5-chloroanthranilate) 5.0 g (29.1 mmol) of 5-chloroanthranilic acid and 15% by mass ammonia methanol were placed in a glass container having an internal volume of 50 ml equipped with a stirrer and a thermometer. A solution (20 ml, 156 mmol) was added, and the mixture was reacted at room temperature for 2 hours. After completion of the reaction, the reaction solution was concentrated under reduced pressure to obtain 5.0 g of ammonium 5-chloroanthranilate as a pale yellow solid (isolated yield: 95%). In addition, ammonium 5-chloroanthranilate is a novel compound having the following physical properties.
【0038】融点(昇華);161〜162℃1
H-NMR(DMSO-d6,δ(ppm));6.57(1H,d,J=8.4Hz)、6.99
(1H,dd,J=2.7,8.4Hz)、7.0(3H,brs)、7.65(1H,d,2.7H
z)、11.0(3H,brs)Melting point (sublimation): 161-162 ° C. 1 H-NMR (DMSO-d 6 , δ (ppm)); 6.57 (1 H, d, J = 8.4 Hz), 6.99
(1H, dd, J = 2.7,8.4Hz), 7.0 (3H, brs), 7.65 (1H, d, 2.7H
z), 11.0 (3H, brs)
【0039】実施例3(6-クロロキナゾリン-4-オンの
合成)
内容積2mlのステンレス製耐圧容器に、参考例3と同様
な方法で合成した5-クロロアントラニル酸アンモニウム
340mg(1.8mmol)、オルトギ酸メチル400mg(3.6mmol)及び
メタノール1.5mlを加え、120℃で2時間反応させた。反
応終了後、室温まで冷却し、反応液を高速液体クロマト
グラフィーにより分析(絶対定量法)したところ、6-ク
ロロキナゾリン-4-オンが307mg生成していた(反応収
率:94%)。Example 3 (Synthesis of 6-chloroquinazolin-4-one) Ammonium 5-chloroanthranilate synthesized in the same manner as in Reference Example 3 was placed in a stainless steel pressure vessel having an internal volume of 2 ml.
340 mg (1.8 mmol), methyl orthoformate 400 mg (3.6 mmol) and methanol 1.5 ml were added and reacted at 120 ° C. for 2 hours. After completion of the reaction, the reaction solution was cooled to room temperature and analyzed by high performance liquid chromatography (absolute quantitative method). As a result, 307 mg of 6-chloroquinazolin-4-one was produced (reaction yield: 94%).
【0040】実施例4(6-クロロキナゾリン-4-オンの
合成)
内容積2mlのステンレス製耐圧容器に、参考例3と同様
な方法で合成した5-クロロアントラニル酸アンモニウム
340mg(1.8mmol)、オルトギ酸メチル400mg(3.6mmol)及び
アセトニトリル1.5mlを加え、120℃で2時間反応させ
た。反応終了後、室温まで冷却し、反応液を高速液体ク
ロマトグラフィーにより分析(絶対定量法)したとこ
ろ、6-クロロキナゾリン-4-オンが303mg生成していた
(反応収率:93%)。Example 4 (Synthesis of 6-chloroquinazolin-4-one) Ammonium 5-chloroanthranilate synthesized in the same manner as in Reference Example 3 was placed in a pressure-resistant stainless steel container having an internal volume of 2 ml.
340 mg (1.8 mmol), methyl orthoformate 400 mg (3.6 mmol) and acetonitrile 1.5 ml were added, and the mixture was reacted at 120 ° C. for 2 hours. After completion of the reaction, the mixture was cooled to room temperature, and the reaction mixture was analyzed by high performance liquid chromatography (absolute quantitative method) to find that 6-chloroquinazolin-4-one (303 mg) was formed
(Reaction yield: 93%).
【0041】参考例4(5-ヨードアントラニル酸アンモ
ニウムの合成)
攪拌装置及び温度計を備えた内容積200mlのガラス製容
器に、5-ヨードアントラニル酸10.0g(38mmol)及び15質
量%アンモニアメタノール溶液100ml(780mmol)を加え、
室温で3時間反応させた。反応終了後、反応液を減圧下
で濃縮し、淡赤色固体として、5-ヨードアントラニル酸
アンモニウム9.0gを得た(単離収率:85%)。なお、5-ヨ
ードアントラニル酸アンモニウムは以下の物性値で示さ
れる新規な化合物である。Reference Example 4 (Synthesis of ammonium 5-iodoanthranilate) In a glass container having an inner volume of 200 ml equipped with a stirrer and a thermometer, 10.0 g (38 mmol) of 5-iodoanthranilic acid and a 15% by mass ammonia methanol solution were prepared. Add 100 ml (780 mmol),
The reaction was carried out at room temperature for 3 hours. After completion of the reaction, the reaction solution was concentrated under reduced pressure to obtain 9.0 g of ammonium 5-iodoanthranilate as a light red solid (isolated yield: 85%). In addition, ammonium 5-iodoanthranilate is a novel compound having the following physical properties.
【0042】融点(分解);160℃1
H-NMR(DMSO-d6,δ(ppm));6.45(1H,d,J=8.7Hz)、6.5
(3H,brs)、7.25(1H,dd,J=2.4,8.7Hz)、7.96(1H,d,J=2.4
Hz)、11.0(3H,brs)Melting point (decomposition): 160 ° C. 1 H-NMR (DMSO-d 6 , δ (ppm)); 6.45 (1 H, d, J = 8.7 Hz), 6.5
(3H, brs), 7.25 (1H, dd, J = 2.4,8.7Hz), 7.96 (1H, d, J = 2.4
Hz), 11.0 (3H, brs)
【0043】実施例5(6-ヨードキナゾリン-4-オンの
合成)
内容積2mlのステンレス製耐圧容器に、参考例4と同様
な方法で合成した5-ヨードアントラニル酸アンモニウム
530mg(1.9mmol)、オルトギ酸メチル403mg(3.8mmol)及び
メタノール1.5mlを加え、120℃で2時間反応させた。反
応終了後、室温まで冷却し、反応液を高速液体クロマト
グラフィーにより分析(絶対定量法)したところ、6-ヨ
ードキナゾリン-4-オンが402mg生成していた(反応収
率:77%)。Example 5 (Synthesis of 6-iodoquinazolin-4-one) Ammonium 5-iodoanthranilate synthesized in the same manner as in Reference Example 4 was placed in a stainless steel pressure vessel having an internal volume of 2 ml.
530 mg (1.9 mmol), methyl orthoformate 403 mg (3.8 mmol) and methanol 1.5 ml were added and reacted at 120 ° C. for 2 hours. After completion of the reaction, the reaction solution was cooled to room temperature and analyzed by high performance liquid chromatography (absolute quantitative method) to find that 402 mg of 6-iodoquinazolin-4-one was produced (reaction yield: 77%).
【0044】実施例6(6-ヨードキナゾリン-4-オンの
合成)
還流冷却器を備えた内容積2mlのガラス製容器に、参考
例4と同様な方法で合成した5-ヨードアントラニル酸ア
ンモニウム530mg(1.9mmol)、オルトギ酸メチル403mg(3.
8mmol)及びn-ブチルアルコール1.5mlを加え、120℃で2
時間反応させた。反応終了後、室温まで冷却し、反応液
を高速液体クロマトグラフィーにより分析(絶対定量
法)したところ、6-ヨードキナゾリン-4-オンが350mg生
成していた(反応収率:67%)。Example 6 (Synthesis of 6-iodoquinazolin-4-one) In a glass container having an inner volume of 2 ml equipped with a reflux condenser, 530 mg of ammonium 5-iodoanthranilate synthesized in the same manner as in Reference Example 4 (1.9 mmol), methyl orthoformate 403 mg (3.
8 mmol) and 1.5 ml of n-butyl alcohol, and add 2 at 120 ° C.
Reacted for hours. After completion of the reaction, the reaction solution was cooled to room temperature and analyzed by high performance liquid chromatography (absolute quantification method). As a result, 350 mg of 6-iodoquinazolin-4-one was produced (reaction yield: 67%).
【0045】[0045]
【発明の効果】本発明により、温和な条件下、簡便な方
法によって、アントラニル酸誘導体のアンモニウム塩か
らキナゾリン-4-オン誘導体を高収率で製造出来る、工
業的に好適なキナゾリン-4-オン誘導体の製造法を提供
することが出来る。INDUSTRIAL APPLICABILITY According to the present invention, an industrially suitable quinazolin-4-one capable of producing a quinazolin-4-one derivative in high yield from an ammonium salt of an anthranilic acid derivative by a simple method under mild conditions. A method for producing a derivative can be provided.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 原田 崇司 山口県宇部市大字小串1978番地の5 宇部 興産株式会社宇部研究所内 (72)発明者 小田 広行 山口県宇部市大字小串1978番地の5 宇部 興産株式会社宇部研究所内 ─────────────────────────────────────────────────── ─── Continued front page (72) Inventor Takashi Harada 5 Ube, 1978, Kogushi, Obu, Ube City, Yamaguchi Prefecture Usan Laboratory, Kosan Co., Ltd. (72) Inventor Hiroyuki Oda 5 Ube, 1978, Kogushi, Obu, Ube City, Yamaguchi Prefecture Usan Laboratory, Kosan Co., Ltd.
Claims (3)
ていても良く、置換基を有していても良い、反応に関与
しない基を示す。なお、R1、R2、R3及びR 4は、
互いに結合して環を形成していても良い。)で示される
アントラニル酸誘導体のアンモニウム塩とギ酸誘導体と
を反応させることを特徴とする、一般式(2) 【化2】 (式中、R1、R2、R3及びR4は、前記と同義であ
る。)で示されるキナゾリン-4-オン誘導体の製造法。1. A general formula (1) [Chemical 1] (In the formula, R1, RTwo, RThreeAnd RFourAre the same or different
May be present or may have a substituent, participates in the reaction
Indicates a group that does not. In addition, R1, RTwo, RThreeAnd R FourIs
They may be bonded to each other to form a ring. )
Ammonium salt of anthranilic acid derivative and formic acid derivative
A general formula (2) characterized by reacting [Chemical 2] (In the formula, R1, RTwo, RThreeAnd RFourIs as defined above
It ) The manufacturing method of the quinazolin-4-one derivative shown by these.
求項1記載のキナゾリン-4-オン誘導体の製造法。2. The method for producing a quinazolin-4-one derivative according to claim 1, wherein the formic acid derivative is an orthoformate ester.
る。但し、R1、R2、R3及びR4が全て水素原子で
ある場合を除く。)で示されるアントラニル酸誘導体の
アンモニウム塩。3. A general formula (2): (In the formula, R 1 , R 2 , R 3 and R 4 have the same meanings as described above, except for the case where all of R 1 , R 2 , R 3 and R 4 are hydrogen atoms.). Ammonium salt of anthranilic acid derivative.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002007014A JP4178793B2 (en) | 2002-01-16 | 2002-01-16 | Process for producing quinazolin-4-one derivative |
PCT/JP2002/013321 WO2003051849A1 (en) | 2001-12-19 | 2002-12-19 | Process for producing quinazolin-4-one and derivative thereof |
AU2002357621A AU2002357621A1 (en) | 2001-12-19 | 2002-12-19 | Process for producing quinazolin-4-one and derivative thereof |
EP02805031A EP1466907B1 (en) | 2001-12-19 | 2002-12-19 | Process for producing quinazolin-4-one and derivative thereof |
AT02805031T ATE519748T1 (en) | 2001-12-19 | 2002-12-19 | METHOD FOR PRODUCING QUINAZOLIN-4-ONE AND DERIVATIVES THEREOF |
US10/499,361 US7232903B2 (en) | 2001-12-19 | 2002-12-19 | Process for producing quinazolin-4-one and derivatives thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002007014A JP4178793B2 (en) | 2002-01-16 | 2002-01-16 | Process for producing quinazolin-4-one derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2003212862A true JP2003212862A (en) | 2003-07-30 |
JP4178793B2 JP4178793B2 (en) | 2008-11-12 |
Family
ID=27645627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002007014A Expired - Fee Related JP4178793B2 (en) | 2001-12-19 | 2002-01-16 | Process for producing quinazolin-4-one derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4178793B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007290974A (en) * | 2006-04-21 | 2007-11-08 | Mitsubishi Gas Chem Co Inc | Method for producing quinazolin-4-one derivative |
-
2002
- 2002-01-16 JP JP2002007014A patent/JP4178793B2/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007290974A (en) * | 2006-04-21 | 2007-11-08 | Mitsubishi Gas Chem Co Inc | Method for producing quinazolin-4-one derivative |
Also Published As
Publication number | Publication date |
---|---|
JP4178793B2 (en) | 2008-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4631703B2 (en) | Method for producing pyrimidin-4-one compound | |
US20080177069A1 (en) | Process for producing 4-aminoquinazoline compound | |
WO2004074264A1 (en) | Process for producing phenylalanine derivative having quinazolinedione skeleton and intermediate for the same | |
JP4788343B2 (en) | Method for producing nitrile compound, carboxylic acid compound or carboxylic acid ester compound | |
Vibhute et al. | An efficient, one-pot three components synthesis of [1, 2, 4] triazoloquinazolinone derivatives using anthranilic acid as green catalyst | |
EP1466907B1 (en) | Process for producing quinazolin-4-one and derivative thereof | |
JP2003212862A (en) | Method for producing quinazolin-4-one derivative | |
JP2003183262A (en) | Method for producing quinazolin-4-one derivative | |
JP4706320B2 (en) | Method for producing N, N-dimethylaminoalkenone compound | |
CN104311469B (en) | A kind of synthetic method of substituted indole-3-acetic acid | |
JP4661786B2 (en) | Method for producing 4-aminopyrimidine compound | |
Şener et al. | Synthesis and some reactions of 4‐(ethoxycarbonyl)‐1, 5‐diphenyl‐1H‐pyrazole‐3‐carboxylic acid | |
JP4517349B2 (en) | Method for producing pyrimidin-4-one compound | |
JP4517337B2 (en) | Preparation of 4-substituted quinazoline compounds | |
JP4639768B2 (en) | Preparation of 4-substituted pyrimidine compounds | |
Andrews et al. | Synthesis and antibacterial activity of 1, 3, 4-oxadiazole substituted pyrimidine derivatives | |
JP4639523B2 (en) | Process for producing 6,7-dioxyquinazolone derivatives | |
US20080306287A1 (en) | Process for Preparing Tetrahydropyran-4-Carboxylic Acid Compound | |
More | Synthesis and characterization of some new biologically active Pyrimidine derivatives | |
WO2003064377A1 (en) | 4,5-substituted-2-formylaminobenzamides and processes for their production and conversion | |
JP3407040B2 (en) | Method for producing quinazoline derivative | |
JP2006347888A (en) | Method for producing 2-aralkyl- or heteroaralkyl-malonic acid compound | |
Barat et al. | INTERNATIONAL JOURNAL OF ENGINEERING SCIENCES & RESEARCH TECHNOLOGY SYNTHESIS AND IN VITRO PHARMACOLOGICAL STUDIES OF SOME NOVEL PRECURSORS OF 6, 8-DIBROMOQUINAZOLIN-4 (3H) ONE | |
JP2002241350A (en) | Method for producing mononitrated aromatic ethers | |
JPH07233120A (en) | Production of 3-(p-fluorophenyl)-2-methylpropionic acid and its derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080129 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20080131 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080331 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080513 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080714 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080805 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080818 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110905 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110905 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110905 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120905 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120905 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120905 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130905 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130905 Year of fee payment: 5 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |